SEC Form 4 · accession 0001209191-17-030122
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Watkins
Director
Period of report
May 3, 2017
Accepted (ET)
May 4, 2017 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 3, 2017 | M | 13,953 | — | A | 19,211 | I | By Trust |
| Ordinary Shares | holding | — | — | — | 6,000 | D | ||
| Ordinary Shares | holding | — | — | — | 10,000 | I | By Family Limited Partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 3, 2017 | M | 13,953 | D | — | — | Ordinary shares | 13,953 | 0 | D |
| Stock Option (Right to Buy)F3 | $15.12 | May 3, 2017 | A | 31,153 | A | — | May 2, 2027 | Ordinary shares | 31,153 | 31,153 | D |
| Restricted Stock UnitsF1 | — | May 3, 2017 | A | 14,054 | A | May 3, 2018 | — | Ordinary shares | 14,054 | 14,054 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.
- F3The option vests in 12 equal monthly installments from the date of grant.